🔎 Trials Near Me

Akèy › Sklerodèm

Etid klinik pou Sklerodèm ap rekrite nan Etazini

33 etid pou Sklerodèm ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07497087

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06655155

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717

FT839 in Autoimmune Diseases

Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT07800871

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06925542

Platform Clinical Study for Conquering Scleroderma

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

Ap rekriteFaz 2
Laj 8 a 60 · Tout sèks · Mizajou Aug 14, 2026 · NCT03630211

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935

A Study of AZD0120 in Autoimmune Diseases

Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07295847

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT07090226

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07115745

Systemic Sclerosis DIet for GastrointESTinal Symptoms

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT07402226

US Zamto-cel Autoimmune Diseases

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT06708845

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Ap rekriteFaz 1
Laj 12 a 70 · Tout sèks · Mizajou May 22, 2026 · NCT06308978

Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Jiska laj 90 · Tout sèks · Mizajou May 12, 2026 · NCT01808937

Intralesional Injection of STS in Treatment of Calcinosis

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT06672822

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 31, 2026 · NCT07047690

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Mar 27, 2026 · NCT03844061

Open Label Treprostinil Raynaud's Study

Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT07112183

Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.